June 11, 2020 / 1:12 PM / 23 days ago

BRIEF-INmune Bio Receives Regulatory Approval From UK MHRA To Initiate Phase I Trial Of INKmune

June 11 (Reuters) - INmune Bio Inc:

* INMUNE BIO, INC. RECEIVES REGULATORY APPROVAL FROM UK MHRA TO INITIATE PHASE I TRIAL OF INKMUNE IN PATIENTS WITH HIGH-RISK MDS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below